Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Andreia Pereira is active.

Publication


Featured researches published by Andreia Pereira.


Endocrine-related Cancer | 2013

Deregulated expression of selected histone methylases and demethylases in prostate carcinoma.

Filipa Vieira; Pedro Costa-Pinheiro; João Ramalho-Carvalho; Andreia Pereira; Francisco Menezes; Luís Antunes; Isa Carneiro; Jorge Oliveira; Rui Henrique; Carmen Jerónimo

Prostate cancer (PCa), a leading cause of cancer-related morbidity and mortality, arises through the acquisition of genetic and epigenetic alterations. Deregulation of histone methyltransferases (HMTs) or demethylases (HDMs) has been associated with PCa development and progression. However, the precise influence of altered HMTs or HDMs expression and respective histone marks in PCa onset and progression remains largely unknown. To clarify the role of HMTs and HDMs in prostate carcinogenesis, expression levels of 37 HMTs and 20 HDMs were assessed in normal prostate and PCa tissue samples by RT-qPCR. SMYD3, SUV39H2, PRMT6, KDM5A, and KDM6A were upregulated, whereas KMT2A-E (MLL1-5) and KDM4B were downregulated in PCa, compared with normal prostate tissues. Remarkably, PRMT6 was the histone modifier that best discriminated normal from tumorous tissue samples. Interestingly, EZH2 and SMYD3 expression levels significantly correlated with less differentiated and more aggressive tumors. Remarkably, SMYD3 expression levels were of independent prognostic value for the prediction of disease-specific survival of PCa patients with clinically localized disease submitted to radical prostatectomy. We concluded that expression profiling of HMTs and HDMs, especially SMYD3, might be of clinical usefulness for the assessment of PCa patients and assist in pre-therapeutic decision-making.


Journal of Human Hypertension | 1997

Genetic and environmental factors regulating blood pressure in childhood: prospective study from 0 to 3 years

António Guerra; Monteiro C; L. Breitenfeld; H Jardim; Carla Rego; D.A. Silva; A. Prata; J Matos; Andreia Pereira; N Teixeira Santos; Manuel Bicho

Objectives: Blood pressure (BP) regulation depends on the interaction between multiple environmental and genetic factors. Of these, BP sensitivity to dietary sodium intake has been one that has been investigated in adults but not in children. The aim of the present study was to investigate, prospectively, the BP profile in relation to different genetic and hormonal factors, in the first 3 years of life. Population and methods: Thirty-nine children born at term following normal pregnancies, with uncomplicated neonatal periods, were randomly selected to take part in the study. BP, weight and length were evaluated every 3 months from birth to 3 years. At the age of 12 months, haptoglobin phenotypes and plasma active renin concentration were determined as well as random urine evaluation of aldosterone, cAMP, dopamine and digoxin-like immunoreactive substances (DLIS). Family history of cardio-vascular diseases was also recorded. Results: Systolic BP (SBP) demonstrated a gradual increase until the age of 6 months with little variation up to 36 months. Tracking of SBP values was also observed from the first year as infants with high values (above the 75 percentile) maintained this tendency up to, at least, the age of 36 months. The comparison between SBP and diastolic BP (DBP) according haptoglobin phenotypes demonstrated that SBP was systematically higher in allele 1, with apparently an increasing tendency with age, although the differences did not have statistical significance. The comparative study between haptoglobin phenotypes, with correction for the covariates fractional excretion of sodium and potassium, showed that allele 1 carriers had significantly lower plasma renin and urine aldosterone and cAMP concentrations than allele 2, but dopamine excretion was found to be higher in allele 1 than in allele 2. There were no differences among variables relating to family history of cardiovascular disease. Conclusions: There was an early tracking process of BP values from the first 6 months of life which persists through, at least, to the age of 36 months. Differences in sodium handling between haptoglobin 1 and 2 phenotypes were already present in early childhood, although no significant repercussion in BP values could be demonstrated in the 3-year duration of this study.


Medicine | 2017

Relationship between ADD1 Gly460Trp gene polymorphism and essential hypertension in Madeira Island

Ana Célia Sousa; Roberto Palma dos Reis; Andreia Pereira; S. Borges; Ana Isabel Freitas; Graça Guerra; Teresa Góis; Mariana Rodrigues; Eva Henriques; S. Freitas; I. Ornelas; Décio Pereira; António Brehm; Maria Isabel Mendonça

Abstract Essential hypertension (EH) is a complex disease in which physiological, environmental, and genetic factors are involved in its genesis. The genetic variant of the alpha-adducin gene (ADD1) has been described as a risk factor for EH, but with controversial results. The objective of this study was to evaluate the association of ADD1 (Gly460Trp) gene polymorphism with the EH risk in a population from Madeira Island. A case-control study with 1614 individuals of Caucasian origin was performed, including 817 individuals with EH and 797 controls. Cases and controls were matched for sex and age, by frequency-matching method. All participants collected blood for biochemical and genotypic analysis for the Gly460Trp polymorphism. We further investigated which variables were independently associated to EH, and, consequently, analyzed their interactions. In our study, we found a significant association between the ADD1 gene polymorphism and EH (odds ratio 2.484, P = .01). This association remained statistically significant after the multivariate analysis (odds ratio 2.548, P = .02). The ADD1 Gly460Trp gene polymorphism is significantly and independently associated with EH risk in our population. The knowledge of genetic polymorphisms associated with EH is of paramount importance because it leads to a better understanding of the etiology and pathophysiology of this pathology.


Revista Portuguesa De Pneumologia | 2018

A variante genética c825t da subunidade β3 da proteína G associa‐se com a hipertensão arterial numa população portuguesa

Ana Célia Sousa; Roberto Palma dos Reis; Andreia Pereira; S. Borges; Sara Gouveia; Adelaide Spínola; Ana Isabel Freitas; Graça Guerra; Teresa Góis; Mariana Rodrigues; Eva Henriques; I. Ornelas; C. Freitas; Décio Pereira; António Brehm; Maria Isabel Mendonça

INTRODUCTION Hypertension is an important public health problem, affecting about 25% of the adult population worldwide.1 Genetic and environmental factors contribute to its pathogenesis. The T allele of the C825T polymorphism of the beta 3 subunit of G protein (rs5443) leads to the production of a truncated variant that enhances intracellular signaling and may interfere with the regulation of blood pressure. This genetic variant has been described as a risk factor for hypertension, although study results are controversial. OBJECTIVE The objective of this study was to analyze the association of the C825T polymorphism of the GNB3 gene with the occurrence of hypertension in a Portuguese population from the Madeira archipelago. METHODS A case-control study was performed with 1641 Caucasian individuals (mean age 50.6±8.1 years), 848 with hypertension and 793 controls. Blood was collected from all participants for biochemical and genetic analysis, including genotyping of the C825T polymorphism. Logistic regression analysis was performed to determine which variables were significantly associated with the onset of hypertension. Statistical analyses were performed using IBM SPSS version 19.0 and p-values <0.05 were considered statistically significant. RESULTS In our study, there was a significant association between the C825T polymorphism of the GNB3 gene and the occurrence of hypertension (odds ratio 1.275; 95% confidence interval 1.042-1.559; p=0.018) in the dominant model, after multivariate analysis. CONCLUSION We conclude that the C825T polymorphism of the beta 3 subunit of G protein is significantly and independently associated with the occurrence of hypertension in the study population.


Biochimica et Biophysica Acta | 2018

Sit4p-mediated dephosphorylation of Atp2p regulates ATP synthase activity and mitochondrial function

Clara Pereira; Andreia Pereira; Hugo Osório; Pedro Moradas-Ferreira; Vitor Santos Costa

Sit4p is a type 2A-related protein phosphatase in Saccharomyces cerevisiae involved in a wide spectrum of cellular functions, including the glucose repression of mitochondrial transcription. Here we report that Sit4p is also involved in post-translational regulation of mitochondrial proteins and identified 9 potential targets. One of these, the ATP synthase (FoF1 complex) beta subunit Atp2p, was characterized and two phosphorylation sites, T124 and T317, were identified. Expression of Atp2p-T124 or T317 phosphoresistant versions in sit4Δ cells decreased Atp2p phosphorylation confirming these as Sit4p-regulated sites. Moreover, Sit4p and Atp2p interacted both physically and genetically. Mimicking phosphorylation at T124 or T317 increased Atp2p levels, resulting in higher abundance/activity of ATP synthase. Similar changes were observed in sit4Δ cells in which Atp2p is endogenously more phosphorylated. Expression of Atp2-T124 or T317 phosphomimetics also increased mitochondrial respiration and ATP levels and extended yeast lifespan. These results suggest that Sit4p-mediated dephosphorylation of Atp2p-T124/T317 downregulates Atp2p alongside with ATP synthase and mitochondrial function. Combination of transcriptional with post-translational regulation during fermentative growth may allow for a more efficient Sit4p repression of mitochondrial respiration.


Arquivos Brasileiros De Cardiologia | 2018

Genetic Risk Analysis of Coronary Artery Disease in a Population-based Study in Portugal, Using a Genetic Risk Score of 31 Variants

Andreia Pereira; Maria Isabel Mendonça; S. Borges; S. Freitas; Eva Henriques; Mariana Rodrigues; Ana Isabel Freitas; Ana Célia Sousa; António Brehm; Roberto Palma dos Reis

Background Genetic risk score can quantify individual’s predisposition to coronary artery disease; however, its usefulness as an independent risk predictor remains inconclusive. Objective To evaluate the incremental predictive value of a genetic risk score to traditional risk factors associated with coronary disease. Methods Thirty-three genetic variants previously associated with coronary disease were analyzed in a case-control population with 2,888 individuals. A multiplicative genetic risk score was calculated and then divided into quartiles, with the 1st quartile as the reference class. Coronary risk was determined by logistic regression analysis. Then, a second logistic regression was performed with traditional risk factors and the last quartile of the genetic risk score. Based on this model, two ROC curves were constructed with and without the genetic score and compared by the Delong test. Statistical significance was considered when p values were less than 0.05. Results The last quartile of the multiplicative genetic risk score revealed a significant increase in coronary artery disease risk (OR = 2.588; 95% CI: 2.090-3.204; p < 0.0001). The ROC curve based on traditional risk factors estimated an AUC of 0.72, which increased to 0.74 when the genetic risk score was added, revealing a better fit of the model (p < 0.0001). Conclusions In conclusion, a multilocus genetic risk score was associated with an increased risk for coronary disease in our population. The usual model of traditional risk factors can be improved by incorporating genetic data.


international engineering management conference | 2008

Do R&D and marketing departments perceive innovation fundamentals through the same lenses?

Andreia Pereira; Jose Sequeira

Todaypsilas competitive world, no matter what industry we are considering, has innovation as a key element for the survival and growth of firms. The product development process tends to be central to the sustainability of firms, emerging the need of top management and the different departments to focus on innovation and to perceive this same objective as a common path which has to be taken together. The literature stresses that Marketing and R&D, the leading departments on the innovation process within firms, have to work jointly to achieve the market success of the innovative product. Usually, this stream of the literature discusses the integration issue focusing essentially on the outcomes - failure/success factors of the innovation process - derived from the (lack of) integration between these departments. In the present paper we assess how close are the perceptions of these departments on the innovation process through the use of an innovation audit. To our knowledge, no study has used the innovation audit to assess the integration of Marketing and R&D departments. The study was applied to a set of key actors within the Marketing and R&D departments of a Portuguese beverage firm. Being a case study, due to the limitation of its sample, it evidences an actual divergence of global perceptions regarding to the firmpsilas innovation process and performance. These results highlights the need for departmentspsila integration not only on the outcomes, but they also indicate that a big effort should be employed in order to close perceptionpsilas gaps on Strategy, Process, Linkages, Learning and Organization, i.e. the fundamentals of innovation, namely by improving intra- and interdepartmental communication.


International Journal of Quantum Chemistry | 2017

Benchmarking of density functionals for the kinetics and thermodynamics of the hydrolysis of glycosidic bonds catalyzed by glycosidases

Andreia Pereira; António J. M. Ribeiro; Pedro A. Fernandes; Maria J. Ramos


Acta Pediátrica Portuguesa | 2010

Morte súbita no jovem atleta: o estado da arte

Cláudia Calado; Andreia Pereira; Ana Teixeira; Rui Anjos


Revista Portuguesa De Pneumologia | 2009

Clinical and angiographic profile of the diabetic patient: one-year follow-up.

M.G. Serrao; Andreia Pereira; N. Santos; Bruno Silva; Graça Caires; D. Freitas; Décio Pereira; Jorge Araújo; Cardoso A

Collaboration


Dive into the Andreia Pereira's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Francisco Menezes

Instituto Português de Oncologia Francisco Gentil

View shared research outputs
Researchain Logo
Decentralizing Knowledge